* Microbot Medical Inc MBOT.OQ reported a quarterly
adjusted
loss of 49 cents per share for the quarter ended in September.
The lone analyst forecast for the quarter was for a loss of 51
cents per share.
* Reported revenue was zero; analysts expected zero.
* Microbot Medical Inc's reported EPS for the quarter was a
loss
of 49 cents.
* The mean earnings estimate of analysts had fallen by
about 6.3%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Microbot Medical Inc shares had fallen by 15.1% this
quarter and
lost 45.9% so far this year.
* The company reported a quarterly loss of $3.47 million.
* Wall Street's median 12-month price target for Microbot
Medical
Inc is $20.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
17 at 01:11 a.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.51 -0.49 Beat
Jun. 30 2022 -0.45 -0.49 Missed
Mar. 31 2022 -0.42 -0.45 Missed
Dec. 31 2021 -0.37 -0.54 Missed